BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 17668070)

  • 1. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
    Efferth T; Giaisi M; Merling A; Krammer PH; Li-Weber M
    PLoS One; 2007 Aug; 2(8):e693. PubMed ID: 17668070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.
    Ganguly A; Basu S; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Chaudhuri SK
    Mol Biosyst; 2011 May; 7(5):1701-12. PubMed ID: 21409205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative.
    Ganguly A; Banerjee K; Chakraborty P; Das S; Sarkar A; Hazra A; Banerjee M; Maity A; Chatterjee M; Mondal NB; Choudhuri SK
    Biomed Pharmacother; 2011 Sep; 65(6):387-94. PubMed ID: 21715129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin.
    Rogalska A; Gajek A; Szwed M; Jóźwiak Z; Marczak A
    Toxicol In Vitro; 2011 Dec; 25(8):1712-20. PubMed ID: 21896327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N,N-Dimethyl phytosphingosine sensitizes HL-60/MX2, a multidrug-resistant variant of HL-60 cells, to doxorubicin-induced cytotoxicity through ROS-mediated release of cytochrome c and AIF.
    Kim BM; Choi YJ; Lee YH; Joe YA; Hong SH
    Apoptosis; 2010 Aug; 15(8):982-93. PubMed ID: 20512627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro.
    Khdair A; Handa H; Mao G; Panyam J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):214-22. PubMed ID: 18796331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancer.
    Basu S; Ganguly A; Chakraborty P; Sen R; Banerjee K; Chatterjee M; Efferth T; Choudhuri SK
    Biochimie; 2012 Jan; 94(1):166-83. PubMed ID: 22037022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds.
    Gruber L; Abdelfatah S; Fröhlich T; Reiter C; Klein V; Tsogoeva SB; Efferth T
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29642419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MZ3 induces apoptosis in human leukemia cells.
    Fang L; He Q; Hu Y; Yang B
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):397-405. PubMed ID: 16900371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
    Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
    Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
    Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-malarial artesunate is also active against cancer.
    Efferth T; Dunstan H; Sauerbrey A; Miyachi H; Chitambar CR
    Int J Oncol; 2001 Apr; 18(4):767-73. PubMed ID: 11251172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells.
    Mamot C; Ritschard R; Wicki A; Küng W; Schuller J; Herrmann R; Rochlitz C
    J Drug Target; 2012 Jun; 20(5):422-32. PubMed ID: 22519893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis in HL-60 cells through the ROS-mediated mitochondrial pathway by ramentaceone from Drosera aliciae.
    Kawiak A; Zawacka-Pankau J; Wasilewska A; Stasilojc G; Bigda J; Lojkowska E
    J Nat Prod; 2012 Jan; 75(1):9-14. PubMed ID: 22250825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
    Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
    Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors determining sensitivity or resistance of tumor cell lines towards artesunate.
    Sertel S; Eichhorn T; Sieber S; Sauer A; Weiss J; Plinkert PK; Efferth T
    Chem Biol Interact; 2010 Apr; 185(1):42-52. PubMed ID: 20144594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines.
    Reske SN; Deisenhofer S; Glatting G; Zlatopolskiy BD; Morgenroth A; Vogg AT; Buck AK; Friesen C
    J Nucl Med; 2007 Jun; 48(6):1000-7. PubMed ID: 17504875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting biliverdin reductase overcomes multidrug resistance in leukemia HL60 cells.
    Kim SS; Seong S; Lim SH; Kim SY
    Anticancer Res; 2013 Nov; 33(11):4913-9. PubMed ID: 24222129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate.
    Dell'Eva R; Pfeffer U; Vené R; Anfosso L; Forlani A; Albini A; Efferth T
    Biochem Pharmacol; 2004 Dec; 68(12):2359-66. PubMed ID: 15548382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.